Represented 20 Czech and Slovak manufacturers in the healthcare sector in the Middle East and Africa
Participated in the preparation of feasibility studies for the construction of hospitals in the region
Mirek is the main holder of all know-how and majority shareholder of the technology for the production of blood plasma substitute
Pavel Kubů, MD
Chief Medical Officer
Leading expert on the use of cannabis products in medical practice
Advisor to the National Drug Coordinator for Digitalisation
Pavel is responsible for the clinical side of this project
Milan Matějů
Business Development Co-founder
He has been representing Czech companies in Africa for more than 10 years. For the last 5 years he has been specialising in the field of medical devices sales
He has experience in opening new markets and has a network of contacts with distributors
Milan is responsible for the business side of the project and raising investment funds
Pierre Debs, Ph.D.
Advisor
He has more than 20 years of research experience in stem cell biology, genetic engineering, somatic cell reprogramming and endocannabinoid system
He has introduced and implemented the use of medical cannabis into the German medical system
Pierre is our main advisor for medical cannabis products and R&D
Associate Professor Irena Šlamborová, Ph.D.
Patent author
Author of a patent for a blood plasma substitute
Leading expert on research into the use of nanomaterials in medical practice
Irena is responsible for leading the research work in the development of our project
Associate Professor Tomáš Vontor, PharmD, Eng., CSc.
Expert guarantor
He was engaged in research and development of new drugs including GMP (Good Manufacturing Practice)
He has worked for a number of pharmaceutical companies in the Czech Republic, USA, Italy and Slovakia
He is an expert guarantor of the project
"Edestin as an organic substitute for blood albumin opens up a wealth of possibilities in therapeutic applications."